Trial
NCT01938833
Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Collaborators
Celgene Corporation
Condition
HER2-negative Breast Cancer
Intervention
Romidepsin
Why stopped
Closed by Sponsor
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-16